Today there is a massive $13.6 billion neurostimulation devices market developing for the ongoing study of the vast arrays of the brain’s neural connections. (1) The diagnostic electrode technology currently used to detect neurological disorders is the same that was developed way back in the 1960s. (2) This is where NeuroOne Medical Technologies (NASDAQ:NMTC) comes into play.
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders that may improve patient outcomes and reduce procedural costs.
Mayo Clinic began testing NeuroOne’s technology in preclinical models and clinical research in 2015 and is presently a top shareholder. (3) NeuroOne Evo electrode product line is complementary to Zimmer Biomet’s ROSA ONE Brain platform used in minimally invasive neurosurgeries. (3) NeuroOne has received FDA approval for their Evo Cortical and sEEG Electrodes. (4) This innovative company is behind the scenes bringing what once could be considered science-fiction-inspired technologies to the brink of creation or they already have it in development. And thanks to NeuroOne’s strategic partnerships they expect their technologies to be widely adopted in the near future. Click HERE to read more about why The Future of Neuroscience is Built on This Thin Film Electrode Technology
Other companies in NeuroOne Medical Tech’s space includes ENDRA Life Sciences (NASDAQ:NDRA), Second Sight Medical (NASDAQ:EYES), Bluejay Diagnostics (NASDAQ:BJDX), Motus GI Hldgs (NASDAQ:MOTS), and Tivic Health Systems (NASDAQ:TIVC). It could be interesting to research if Tesla’s (NASDAQ:TSLA) co-founder Elon Musk’s company Neuralink and NeuroOne Medical Technologies (NASDAQ:NMTC) have anything in common. As always conduct your own due diligence.
Source 1: https://www.gminsights.com/pressrelease/neurostimulation-devices-market-size
Source 2: https://n1mtc.com/investorsSource
Source 3: https://seekingalpha.com/article/4470806-neuroone-nmtc-stock-thin-film-electrodes-neurological-conditions
Source 4: https://www.mpo-mag.com/contents/view_breaking-news/2021-12-08/fda-clears-neuroone-medical-technologies-evo-seeg-electrode/
For consideration of being featured on WallstreetPR, contact: Editor@Wallstreetpr.com